Skip to main content

Michael N. Hall








Michael N. Hall


From Wikipedia, the free encyclopedia

Jump to navigation
Jump to search














Michael N. Hall

Michael N Hall 2014.jpg
Michael N. Hall (2014)

Nationality
Swiss, American
Alma mater
University of North Carolina at Chapel Hill (B.S., 1976)
Harvard University (Ph.D., 1981)
Known for
mTOR
Awards
Louis-Jeantet Prize for Medicine (2009) [1]
Marcel Benoist Prize (2012)
Lasker Prize (2017)

Scientific career
Fields
Molecular biology
Institutions
University of North Carolina at Chapel Hill
Harvard University
Institut Pasteur
University of California, San Francisco
Biozentrum University of Basel

Michael Nip Hall is an American and Swiss molecular biologist and Professor at the Biozentrum University of Basel, Switzerland.




Contents





  • 1 Life


  • 2 Work


  • 3 Awards and honors


  • 4 References


  • 5 External links




Life[edit]


Hall grew up in South America (Venezuela, Peru). He earned a Bachelor of Science in Zoology from the University of North Carolina at Chapel Hill in 1976, and a PhD in Molecular Genetics from Harvard University in 1981. Hall was a postdoctoral fellow at the Institut Pasteur in Paris and at the University of California, San Francisco. He was appointed an Assistant Professor at the Biozentrum of the University of Basel in 1987, and became a Full Professor in 1992. From 1995 to 1998 and from 2002 to 2009 he was head of the Division of Biochemistry, and from 2002 until 2009 was Deputy Director of the Biozentrum.[2]



Work[edit]


Hall is a pioneer in the fields of TOR signaling and cell growth control.[3] In 1991, Michael N. Hall discovered a protein, which regulates cell growth, cell size and cell division in yeast cells.[4] Since the function of this protein is inhibited by the substance rapamycin, Hall gave the growth regulator the name «Target of Rapamycin» or for short «TOR». TOR is a conserved protein kinase activated by growth factors, nutrients, and insulin. It is a central controller of cell growth and metabolism. TOR plays a key role in aging and the development of diseases such as cancer, obesity, Diabetes mellitus, and cardiovascular disease. Insights into TOR signaling pathways have been applied for new therapeutic strategies. [5][6] Hall received the 2017 Albert Lasker Basic Medical Research Award.[7]



Awards and honors[edit]


  • 1995 Member of the European Molecular Biology Organization (EMBO)[8]

  • 2003 Cloëtta Prize for Biomedical Research[9]

  • 2009 Fellow of the American Association for the Advancement of Science (AAAS)

  • 2009 Louis-Jeantet Prize for Medicine[10]

  • 2012 Marcel Benoist Prize for Humanities or Science[11]

  • 2013 Member of the Swiss Academy of Medical Sciences[12]

  • 2014 Sir Hans Krebs Medal, Federation of European Biochemical Societies (FEBS) [13]

  • 2014 Breakthrough Prize in Life Sciences[14][15]

  • 2014 Synergy Grant, European Research Council (ERC) [16]

  • 2014 Member of the National Academy of Sciences USA[17]

  • 2015 Canada Gairdner International Award[18]

  • 2016 Debrecen Award for Molecular Medicine[19]

  • 2016 Honorary doctorate, University of Geneva[20]

  • 2017 Szent-Györgyi Prize[21]

  • 2017 Lasker Award for Basic Medical Research[22]


References[edit]



  1. ^ Louis-Jeantet Prize


  2. ^ Curriculum Vitae Biozentrum.unibas.ch Retrieved 2013-10-22


  3. ^ Short Biography Archived 2014-10-18 at the Wayback Machine., De Duve Institute Retrieved 2013-10-22


  4. ^ "Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast". Science. 253: 905–9. Aug 1991. doi:10.1126/science.1715094. PMID 1715094. 


  5. ^ Introduction Michael N. Hall Archived 2014-10-16 at the Wayback Machine. bioss.uni-freiburg.de Retrieved 2013-10-22


  6. ^ Unveiling the Secret of Cell Growth Karger.com Retrieved 2015-09-16


  7. ^ Foundation, Lasker. "Nutrient-activated TOR proteins that regulate cell growth | The Lasker Foundation". The Lasker Foundation. Retrieved 2018-03-05. 


  8. ^ European Molecular Biology Organization Membership Guide 2012 Retrieved 2013-10-22


  9. ^ Cloëtta Prize Website Retrieved 2013-10-22


  10. ^ Louis-Jeantet Prize


  11. ^ Marcel Benoist Prize 2012 marcel-benoist.ch Retrieved 2013-10-22


  12. ^ SAMS-Member samw.ch Retrieved 2013-10-22


  13. ^ Sir Hans Krebs Lecture Archived 2014-01-16 at the Wayback Machine. FEBS-EMBO 2014 Retrieved 2013-10-22


  14. ^ First Breakthrough Prize in Life Sciences awarded to Swiss scientist. In: University of Basel, December 13, 2013


  15. ^ "Laureates: 2014". Breakthrough Prize in Life Sciences, Retrieved 2014-02-05. 


  16. ^ "ERC Synergy Grant: EUR 11 million for Cancer Research" In: University of Basel, December 18, 2013


  17. ^ National Academy of Sciences Members and Foreign Associates Elected. Archived 2015-08-18 at the Wayback Machine. nasonline.org Retrieved 2014-06-24


  18. ^ Michael N. Hall: Recipient of the Canada Gairdner International Award, 2015; Gairdner Foundation (gairdner.org); Retrieved 2015-03-31


  19. ^ Debrecen Award for Molecular Medicine 2016; University of Debrecen (unideb.hu); Retrieved 2017-05-23


  20. ^ Doctor honoris causa, University of Geneva 2016; University of Geneva (unige.ch); Retrieved 2017-05-23


  21. ^ Szent-Györgyi Prize 2017; National Foundation for Cancer (nfcr.org); Retrieved 2017-05-23


  22. ^ http://www.laskerfoundation.org/awards/year/2017/



External links[edit]


  • Research Group Michael N. Hall









Retrieved from "https://en.wikipedia.org/w/index.php?title=Michael_N._Hall&oldid=858017123"





Navigation menu

























(window.RLQ=window.RLQ||).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.288","walltime":"0.355","ppvisitednodes":"value":1690,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":33898,"limit":2097152,"templateargumentsize":"value":2437,"limit":2097152,"expansiondepth":"value":12,"limit":40,"expensivefunctioncount":"value":7,"limit":500,"unstrip-depth":"value":0,"limit":20,"unstrip-size":"value":11920,"limit":5000000,"entityaccesscount":"value":1,"limit":400,"timingprofile":["100.00% 286.606 1 -total"," 52.14% 149.437 1 Template:Infobox_scientist"," 48.38% 138.651 1 Template:Infobox_person"," 36.81% 105.502 2 Template:Infobox"," 13.14% 37.647 1 Template:Cite_journal"," 11.15% 31.956 1 Template:Authority_control"," 7.60% 21.795 4 Template:Main_other"," 6.43% 18.436 4 Template:Webarchive"," 6.14% 17.596 5 Template:Br_separated_entries"," 3.78% 10.847 1 Template:Breakthrough_Prize_laureates"],"scribunto":"limitreport-timeusage":"value":"0.104","limit":"10.000","limitreport-memusage":"value":3589220,"limit":52428800,"cachereport":"origin":"mw2258","timestamp":"20180920150121","ttl":1900800,"transientcontent":false);mw.config.set("wgBackendResponseTime":90,"wgHostname":"mw2175"););

Popular posts from this blog

𛂒𛀶,𛀽𛀑𛂀𛃧𛂓𛀙𛃆𛃑𛃷𛂟𛁡𛀢𛀟𛁤𛂽𛁕𛁪𛂟𛂯,𛁞𛂧𛀴𛁄𛁠𛁼𛂿𛀤 𛂘,𛁺𛂾𛃭𛃭𛃵𛀺,𛂣𛃍𛂖𛃶 𛀸𛃀𛂖𛁶𛁏𛁚 𛂢𛂞 𛁰𛂆𛀔,𛁸𛀽𛁓𛃋𛂇𛃧𛀧𛃣𛂐𛃇,𛂂𛃻𛃲𛁬𛃞𛀧𛃃𛀅 𛂭𛁠𛁡𛃇𛀷𛃓𛁥,𛁙𛁘𛁞𛃸𛁸𛃣𛁜,𛂛,𛃿,𛁯𛂘𛂌𛃛𛁱𛃌𛂈𛂇 𛁊𛃲,𛀕𛃴𛀜 𛀶𛂆𛀶𛃟𛂉𛀣,𛂐𛁞𛁾 𛁷𛂑𛁳𛂯𛀬𛃅,𛃶𛁼

Edmonton

Crossroads (UK TV series)